Your browser doesn't support javascript.
loading
Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancer.
Agarwal, Neeraj; Azad, Arun; Shore, Neal D; Carles, Joan; Fay, Andre P; Dunshee, Curtis; Karsh, Lawrence Ivan; Paccagnella, Maria Luisa; Santo, Nicola Di; Elmeliegy, Mohamed; Lin, Xun; Czibere, Akos; Fizazi, Karim.
  • Agarwal N; Huntsman Cancer Institute (NCI-CCC) at the University of Utah, Salt Lake City, UT, USA.
  • Azad A; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA.
  • Carles J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Fay AP; PUCRS School of Medicine Grupo Oncoclínicas, Porto Alegre, Brazil.
  • Dunshee C; Urological Associates of Southern Arizona, Tucson, AZ, USA.
  • Karsh LI; The Urology Center of Colorado, Denver, CO, USA.
  • Paccagnella ML; Pfizer Inc., Groton, CT, USA.
  • Santo ND; Pfizer Inc., Durham, NC, USA.
  • Elmeliegy M; Pfizer Inc., La Jolla, CA, USA.
  • Lin X; Pfizer Inc., La Jolla, CA, USA.
  • Czibere A; Pfizer Inc., Cambridge, MA, USA.
  • Fizazi K; Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France.
Future Oncol ; 18(27): 2979-2986, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35950899

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article